Overview

Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

Status:
RECRUITING
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.
Phase:
PHASE2
Details
Lead Sponsor:
Imbrium Therapeutics
Collaborator:
Purdue Pharma LP